Chimeric antigen receptor (CAR)
Showing 51 - 75 of >10,000
Acute Myeloid Leukemia Trial in Kunming (Anti-CLL1 CART cells)
Recruiting
- Acute Myeloid Leukemia
- Anti-CLL1 CART cells
-
Kunming, Yunnan, ChinaNo.212 Daguan Road, Xishan District
Nov 23, 2022
Ependymoma Trial in New York (HER2 Specific CAR T Cell)
Recruiting
- Ependymoma
- HER2 Specific CAR T Cell
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Apr 6, 2022
Colorectal Cancer, Esophagus Cancer, Gastric Cancer Trial in Hangzhou (CEA-targeted CAR-T cells)
Recruiting
- Colorectal Cancer
- +6 more
- CEA-targeted CAR-T cells
-
Hangzhou, Zhejiang, China
- +1 more
Sep 18, 2023
Recurrent Glioblastoma, Recurrent Malignant Glioma, Recurrent WHO Grade II Glioma Trial in Duarte (Chlorotoxin
Recruiting
- Recurrent Glioblastoma
- +3 more
- Chlorotoxin (EQ)-CD28-CD3zeta-CD19t-expressing CAR T-lymphocytes (via ICT delivery)
- Chlorotoxin (EQ)-CD28-CD3zeta-CD19t-expressing CAR T-lymphocytes (via ICT/ICV dual delivery)
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 25, 2022
Lymphoma, Leukemia, Plasma Cell Dyscrasia Trial in San Francisco (Web Application)
Not yet recruiting
- Lymphoma
- +2 more
- Web Application
-
San Francisco, CaliforniaUniversity of California, San Francisco
Oct 4, 2022
Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma Trial in United States (IMPT-314)
Not yet recruiting
- Relapsed Non-Hodgkin Lymphoma
- Refractory Non-Hodgkin Lymphoma
-
Los Angeles, California
- +3 more
Apr 12, 2023
Lymphoma, Lymphoma, Non-Hodgkin, Immune System Diseases Trial in Chapel Hill (ATLCAR.CD30 cells)
Recruiting
- Lymphoma
- +7 more
- ATLCAR.CD30 cells
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center at University of North Ca
Dec 2, 2022
Immunotherapy, Multiple Myeloma Trial in Zhengzhou (Chimeric Antigen Receptor NK Cell Injection Targeting BCMA (BCMA CAR-NK))
Recruiting
- Immunotherapy
- Multiple Myeloma
- Chimeric Antigen Receptor NK Cell Injection Targeting BCMA (BCMA CAR-NK)
-
Zhengzhou, Henan, ChinaHenan Cancer Hospital
Dec 14, 2022
SLE (Systemic Lupus) Trial in Bangkok (CAR T-cell therapy)
Not yet recruiting
- SLE (Systemic Lupus)
- CAR T-cell therapy
-
Bangkok, Please Select, ThailandKing Chulalongkorn Memorial Hospital
Nov 23, 2023
Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited Trial in Zhengzhou (ThisCART19A, Fludarabine Pill, Cyclophosphamide)
Not yet recruiting
- Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited
- ThisCART19A
- +3 more
-
Zhengzhou, Henan, ChinaHenan cancer hospital
Nov 28, 2022
Sarcoma, HER-2 Protein Overexpression Trial in Houston (cells, Pembrolizumab Injectable Product, Nivolumab Injectable Product)
Recruiting
- Sarcoma
- HER-2 Protein Overexpression
- cells
- +3 more
-
Houston, TexasTexas Children's Hospital
Dec 8, 2021
Chronic GVHD, Hematologic and Lymphocytic Disorder, Steroid Refractory GVHD Trial in Duarte (procedure, biological, other)
Not yet recruiting
- Chronic Graft Versus Host Disease
- +2 more
- Biopsy
- +11 more
-
Duarte, CaliforniaCity of Hope Medical Center
Aug 7, 2023
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Duarte
Not yet recruiting
- Castration-Resistant Prostate Carcinoma
- +2 more
- Autologous Anti-PSCA-CAR-4-1BB/TCRzeta-CD19t-expressing T-lymphocytes
- +7 more
-
Duarte, CaliforniaCity of Hope Medical Center
Apr 5, 2023
Glioma of Spinal Cord, Glioma of Brainstem Trial in Stanford (GD2 CAR T cells, Fludarabine, Cyclophosphamide)
Recruiting
- Glioma of Spinal Cord
- Glioma of Brainstem
- GD2 CAR T cells
- +2 more
-
Stanford, CaliforniaLucile Packard Children's Hospital (LPCH)
Jun 22, 2022
Lymphoblastic Leukemia, Acute, Childhood, Lymphoblastic Leukemia, Lymphoblastic Leukemia, Acute Adult Trial in Singapore (CAR
Recruiting
- Lymphoblastic Leukemia, Acute, Childhood
- +6 more
- CAR T-cell therapy
-
Singapore, SingaporeAllen Yeoh Eng Juh
Sep 7, 2021
Lymphoma Non-Hodgkin, Agressive Lymphoma, Diffuse-large B-cell Lymphoma (DLBCL) Trial in Canada, United States (CC-97540)
Active, not recruiting
- Lymphoma Non-Hodgkin
- +2 more
- CC-97540
-
Birmingham, Alabama
- +13 more
Oct 28, 2022
Non Hodgkin Lymphoma Trial in San Francisco (Neuropsychological testing)
Not yet recruiting
- Non Hodgkin Lymphoma
- Neuropsychological testing
-
San Francisco, CaliforniaStanford Cancer Center
Nov 9, 2022
MT2017-45: CAR-T Cell Therapy for Heme Malignancies
Recruiting
- Acute Lymphoblastic Leukemia
- Large B-cell Lymphoma
- KYMRIAH
- +8 more
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Nov 2, 2022
B-cell Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Charleston (Cyclophosphamide injection, Fludarabine
Not yet recruiting
- B-cell Non Hodgkin Lymphoma
- Chronic Lymphocytic Leukemia
- Cyclophosphamide injection
- +2 more
-
Charleston, South CarolinaHollings Cancer Center at Medical University of South Carolina
Jan 18, 2023
Advanced Glioma, Complication of Chimeric Antigen Receptor (CAR-T) Cell Therapy Trial in Suzhou (Targeted IL-13 Ra2 UCAR-T cell
Recruiting
- Advanced Glioma
- Complication of Chimeric Antigen Receptor (CAR-T) Cell Therapy
- Targeted IL-13 Rα2 UCAR-T cell injection
- Targeted B7-H3 UCAR-T cell injection
-
Suzhou, Jiangsu, ChinaThe Second Affiliated Hospital of Soochow University
Mar 2, 2023
Malignant Tumor, Metastatic Malignant Tumor in the Brain, Metastatic Malignant Tumor in the Leptomeninges Trial in Duarte
Recruiting
- Malignant Neoplasm
- +4 more
- Chimeric Antigen Receptor T-Cell Therapy
-
Duarte, CaliforniaCity of Hope Medical Center
Sep 14, 2022
Large B-cell Lymphoma Trial in Shanghai (BZ019)
Recruiting
- Large B-cell Lymphoma
- BZ019
-
Shanghai, Shanghai, ChinaShanghai Mengchao Cancer Hospital
Jul 21, 2022
Leukemia, Lymphoma, Lymphoma, B-Cell Trial in New York (CAR T-Cell Infusion)
Withdrawn
- Leukemia
- +2 more
- CAR T-Cell Infusion
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Mar 4, 2022
Mantle Cell Lymphoma, Follicular Lymphoma, Splenic Marginal Zone Lymphoma Trial in Chapel Hill (CAR.k.28, Fludarabine,
Recruiting
- Mantle Cell Lymphoma
- +5 more
- CAR.k.28
- +3 more
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center at University of North Ca
Nov 19, 2021